Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
123.43
+0.07 (0.06%)
At close: Jun 18, 2026, 4:00 PM EDT
123.55
+0.12 (0.10%)
After-hours: Jun 18, 2026, 5:27 PM EDT
Nuvalent Market Cap
Nuvalent has a market cap or net worth of $9.75 billion as of June 18, 2026. Its market cap has increased by 76.76% in one year.
Market Cap
9.75B
Enterprise Value
8.46B
1-Year Change
76.76%
Ranking
Category
Stock Price
$123.43
Market Cap Chart
Since the IPO on July 29, 2021, Nuvalent's market cap has increased from $795.96M to $9.75B, an increase of 1,125.02%. That is a compound annual growth rate of 66.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 9.75B | 24.82% |
| Dec 31, 2025 | 7.81B | 40.44% |
| Dec 31, 2024 | 5.56B | 20.68% |
| Dec 29, 2023 | 4.61B | 174.21% |
| Dec 30, 2022 | 1.68B | 82.83% |
| Dec 31, 2021 | 919.33M | 15.50% |
| Jul 29, 2021 | 795.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Madrigal Pharmaceuticals | 11.66B |
| Arrowhead Pharmaceuticals | 11.52B |
| Cytokinetics | 10.70B |
| Summit Therapeutics | 10.67B |
| BioMarin Pharmaceutical | 10.57B |
| Krystal Biotech | 10.26B |
| Bio-Techne | 9.07B |
| Corcept Therapeutics | 8.58B |